Author: Maja von Cube; Marlon Grodd; Martin Wolkewitz; Derek Hazard; Jerome Lambert
                    Title: Harmonizing heterogeneous endpoints in COVID-19 trials without loss of information - an essential step to facilitate decision making  Document date: 2020_4_3
                    ID: bsddxgx2_16
                    
                    Snippet: To obtain a detailed understanding of potential treatment effects, we propose the multistate model shown in Figure 1 For clinical trials that have already been started, we highly recommend to provide the stacked probability plots. Specifically clinical trials using the categorical endpoints recommended by the WHO R&D Blueprint expert group have all the necessary information available for this detailed analysis......
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: To obtain a detailed understanding of potential treatment effects, we propose the multistate model shown in Figure 1 For clinical trials that have already been started, we highly recommend to provide the stacked probability plots. Specifically clinical trials using the categorical endpoints recommended by the WHO R&D Blueprint expert group have all the necessary information available for this detailed analysis.
 
  Search related documents: 
                                Co phrase  search for related documents- Blueprint expert and treatment effect: 1
  - Blueprint expert group and categorical endpoint: 1, 2
  - Blueprint expert group and treatment effect: 1
  - categorical endpoint and treatment effect: 1
  - clinical trial and detailed analysis: 1, 2, 3, 4, 5, 6
  - clinical trial and detailed understanding: 1
  - clinical trial and necessary information: 1, 2, 3, 4
  - clinical trial and potential treatment effect: 1, 2, 3, 4, 5
  - clinical trial and specifically clinical trial: 1, 2, 3, 4
  - clinical trial and start clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
  - clinical trial and treatment effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
  - detailed analysis and necessary information: 1, 2, 3
  - detailed analysis and treatment effect: 1, 2, 3, 4
  - detailed understanding and multistate model: 1, 2
  - detailed understanding and necessary information: 1
  - detailed understanding and potential treatment effect: 1
  - detailed understanding and probability plot: 1
  - detailed understanding and treatment effect: 1, 2
  - multistate model and probability plot: 1, 2, 3
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date